Back to search
Biliary Atresia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Biliary Atresia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Biliary Atresia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the per…
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that c…
This study is non-inferiority trial design. This study aimed to investigate the effect of prophylactic oral antibiotics on preventing cholangitis in biliary atr…
The main objective of this study is to assess the prevalence of dental discoloration (dental dyschromia) in children who experienced high levels of bilirubin in…
Biliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-inva…
This study is a prospective, single center and observational open clinical study.
This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investi…
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia